The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment trends for metastatic urothelial carcinoma across eight Mexican centers: A global oncology perspective.
 
Evelyn Lilian Beas-Lozano
No Relationships to Disclose
 
Yuly Andrea Remolina Bonilla
Honoraria - Asofarma; Pfizer
Travel, Accommodations, Expenses - Ipsen; Lilly
 
Rosa Caballero
No Relationships to Disclose
 
Nora Sobrevilla-Moreno
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb (Mexico); Ipsen; Janssen Oncology; Merck/Pfizer; MSD Oncology; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; MSD Oncology; Pfizer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Merck Serono; MSD Oncology
 
Perla Perez Perez
No Relationships to Disclose
 
Maria Guadalupe Díaz-Alvarado
No Relationships to Disclose
 
Omar Alejandro Alejandro Zayas-Villanueva
No Relationships to Disclose
 
Erika Martinez
No Relationships to Disclose
 
Saul Campos Gomez
No Relationships to Disclose
 
Luis Arturo Cardoso Aparicio
No Relationships to Disclose
 
Dolores Mendoza Oliva
No Relationships to Disclose
 
Maria T. Bourlon
Leadership - BMS
Honoraria - BMS; Tecnofarma; Tecnofarma
Consulting or Advisory Role - Asofarma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Gilead Sciences; Janssen Oncology; Merck; MSD; MSD Oncology; Novartis; Novartis; Pfizer
Speakers' Bureau - Asofarma; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Ipsen; Janssen Oncology; Medicamenta; Merck; MSD Oncology; Pfizer; Tecnofarma
Research Funding - Janssen Oncology (Inst); Pfizer
Expert Testimony - Asofarma
Travel, Accommodations, Expenses - Asofarma; Bristol-Myers Squibb (Mexico); Janssen-Cilag; MSD Oncology; Pfizer
Other Relationship - Sanofi